← Back to Search

Behavioural Intervention

Asthma Link for Childhood Asthma

N/A

Recruiting

Led By Michelle Trivedi, MD

Research Sponsored by University of Massachusetts, Worcester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Must not have

Child: Unable or unwilling to provide informed assent, Developmental delay that would prevent study participation

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 6 months, 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to find out if a program called Asthma Link, supervised by schools, is better at improving asthma symptoms in children aged 5-14 with poorly controlled asthma compared to just using an

Who is the study for?

This trial is for children aged 5-14 with poorly controlled asthma. It's designed to see if a school program called Asthma Link can help manage their symptoms better than an educational workbook.

What is being tested?

The study is testing the effectiveness of 'Asthma Link', which involves supervised asthma therapy at school, against just using an educational workbook on asthma care. Children will be randomly placed in one of these two groups.

What are the potential side effects?

Since specific side effects are not listed for this intervention, they may vary depending on individual reactions to the Asthma Link program or any medications used within it.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My child cannot give informed assent due to developmental delays.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 6 months, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 6 months, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Improving Asthma Symptoms

Secondary study objectives

Improving Healthcare Utilization

Improving Medication Adherence

Improving Quality of Life

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Asthma LinkExperimental Treatment1 Intervention

Practices in the Asthma Link condition will receive brief training on how to identify, refer and arrange for children with poorly controlled asthma to receive school-supervised therapy with the child's school health staff. Participants will receive an educational asthma workbook.

Group II: Enhanced Usual CareActive Control1 Intervention

Practices in the Enhanced Usual Care condition will receive brief training on how to identify and refer the same group of children with poorly controlled asthma and these children will receive an educational asthma workbook.

0 / 1Eligibility criteria met